Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record now shows that recruitment is closed for participants, and the history adds a new revision label v3.6.0 while removing the previous v3.5.5 tag.
    Difference
    0.3%
    Check dated 2026-06-12T16:47:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The history includes a new revision tag v3.5.5, replacing v3.5.4, indicating an updated build of the page.
    Difference
    0.1%
    Check dated 2026-06-05T13:51:23.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a new page build. The change reflects release metadata rather than content updates to the study record.
    Difference
    0.1%
    Check dated 2026-05-15T05:49:57.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The record history page shows a new revision label (v3.5.3) replacing the previous v3.5.2, indicating a fresh release of the page's UI and metadata. This is a metadata update rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-04-30T18:44:08.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added and the previous revision v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-16T11:10:31.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and Revision v3.4.3 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T18:19:03.000Z thumbnail image

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.